Randomised phase III trial of vinflunine plus capecitabine versus capecitabine alone in patients with advanced breast cancer previously treated with an anthracycline and resistant to taxane

Autor: Martin, M. *, Campone, M., Bondarenko, I., Sakaeva, D., Krishnamurthy, S., Roman, L., Lebedeva, L., Vedovato, J.-C., Aapro, M.
Zdroj: In Annals of Oncology May 2018 29(5):1195-1202
Databáze: ScienceDirect